These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10587280)

  • 1. Psychological strategies for discontinuing benzodiazepine treatment.
    Spiegel DA
    J Clin Psychopharmacol; 1999 Dec; 19(6 Suppl 2):17S-22S. PubMed ID: 10587280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder.
    Otto MW; Pollack MH; Sachs GS; Reiter SR; Meltzer-Brody S; Rosenbaum JF
    Am J Psychiatry; 1993 Oct; 150(10):1485-90. PubMed ID: 8379551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication discontinuation in panic disorder.
    Ballenger JC
    J Clin Psychiatry; 1992 Mar; 53 Suppl():26-31. PubMed ID: 1548252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic strategies for discontinuing benzodiazepine treatment.
    Rickels K; DeMartinis N; Rynn M; Mandos L
    J Clin Psychopharmacol; 1999 Dec; 19(6 Suppl 2):12S-16S. PubMed ID: 10587279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predicting the success of a benzodiazepine discontinuation programme: myths or clinical wisdom?].
    Knoop H; Kan CC; Mickers FC; Barnhoorn D
    Tijdschr Psychiatr; 2006; 48(9):695-703. PubMed ID: 17007475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose benzodiazepine dependence: a qualitative study of patients' perception on cessation and withdrawal.
    Liebrenz M; Gehring MT; Buadze A; Caflisch C
    BMC Psychiatry; 2015 May; 15():116. PubMed ID: 25968120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive-behavioral therapy for benzodiazepine discontinuation in panic disorder patients.
    Otto MW; Pollack MH; Meltzer-Brody S; Rosenbaum JF
    Psychopharmacol Bull; 1992; 28(2):123-30. PubMed ID: 1355299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders.
    Uhlenhuth EH; Balter MB; Ban TA; Yang K
    J Clin Psychopharmacol; 1999 Dec; 19(6 Suppl 2):23S-29S. PubMed ID: 10587281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: Adjunctive pharmacologic approaches for benzodiazepine tapers.
    Welsh JW; Tretyak V; McHugh RK; Weiss RD; Bogunovic O
    Drug Alcohol Depend; 2018 Aug; 189():96-107. PubMed ID: 29906718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepines and anxiety sensitivity in panic disorder.
    Fava GA; Grandi S; Belluardo P; Savron G; Raffi AR; Conti S; Saviotti FM
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Nov; 18(7):1163-8. PubMed ID: 7846286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive treatment of benzodiazepine discontinuation syndromes: a review.
    Roy-Byrne PP; Sullivan MD; Cowley DS; Ries RK
    J Psychiatr Res; 1993; 27 Suppl 1():143-53. PubMed ID: 7908331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepines for panic disorder. Are they safe?
    Garvey M
    Postgrad Med; 1991 Oct; 90(5):245-6, 249-52. PubMed ID: 1681526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia.
    Morin CM; Bastien C; Guay B; Radouco-Thomas M; Leblanc J; Vallières A
    Am J Psychiatry; 2004 Feb; 161(2):332-42. PubMed ID: 14754783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internal cue exposure and the treatment of substance use disorders: lessons from the treatment of panic disorder.
    Otto MW; Safren SA; Pollack MH
    J Anxiety Disord; 2004; 18(1):69-87. PubMed ID: 14725869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawing benzodiazepines in primary care.
    Lader M; Tylee A; Donoghue J
    CNS Drugs; 2009; 23(1):19-34. PubMed ID: 19062773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.
    Chouinard G
    J Clin Psychiatry; 2004; 65 Suppl 5():7-12. PubMed ID: 15078112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Discontinuation of benzodiazepines in old age : When and if so, how?].
    Wolter DK
    Z Gerontol Geriatr; 2017 Feb; 50(2):115-122. PubMed ID: 28105500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation.
    Otto MW; McHugh RK; Simon NM; Farach FJ; Worthington JJ; Pollack MH
    Behav Res Ther; 2010 Aug; 48(8):720-7. PubMed ID: 20546699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin as adjunctive therapy in benzodiazepine discontinuation.
    Caniff K; Telega E; Bostwick JR; Gardner KN
    Am J Health Syst Pharm; 2018 Jan; 75(2):67-71. PubMed ID: 29317396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.